Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115352) titled 'A prospective, single-arm, multicenter real-world study observing the efficacy and safety of peginterferon alfa-2b injection in the treatment of patients with PV or ET' on Dec. 25, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Condition:
Polycythemia vera (PV) and essential thrombocythemia (ET)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-12-30
Target Sample Size: PEG-IFN a-2b group:300;
Countries of Recruitment:
China
...